JP2010273685A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010273685A5 JP2010273685A5 JP2010166570A JP2010166570A JP2010273685A5 JP 2010273685 A5 JP2010273685 A5 JP 2010273685A5 JP 2010166570 A JP2010166570 A JP 2010166570A JP 2010166570 A JP2010166570 A JP 2010166570A JP 2010273685 A5 JP2010273685 A5 JP 2010273685A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- antibody
- seq
- vertebrate
- purified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108010036039 Serrate-Jagged Proteins Proteins 0.000 claims 17
- 102000011842 Serrate-Jagged Proteins Human genes 0.000 claims 17
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims 13
- 108020004707 nucleic acids Proteins 0.000 claims 8
- 102000039446 nucleic acids Human genes 0.000 claims 8
- 150000007523 nucleic acids Chemical class 0.000 claims 8
- 102000004169 proteins and genes Human genes 0.000 claims 7
- 108090000623 proteins and genes Proteins 0.000 claims 7
- 102000037865 fusion proteins Human genes 0.000 claims 5
- 108020001507 fusion proteins Proteins 0.000 claims 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 238000000034 method Methods 0.000 claims 3
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 108700024228 Drosophila Ser Proteins 0.000 claims 2
- 102000003839 Human Proteins Human genes 0.000 claims 2
- 108090000144 Human Proteins Proteins 0.000 claims 2
- 108091034117 Oligonucleotide Proteins 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
Claims (23)
- 配列番号2、配列番号6、配列番号14及び配列番号16から成る群より選択されるアミノ酸配列を含む、精製された脊椎動物のSerrateタンパク質。
- 哺乳動物のタンパク質である、請求項1に記載の精製された脊椎動物のSerrateタンパク質。
- ヒトのタンパク質である、請求項1に記載の精製された脊椎動物のSerrateタンパク質。
- 前記ヒトのタンパク質が配列番号2を含む、請求項3に記載の精製された脊椎動物のSerrateタンパク質。
- 配列番号4を含む、精製されたヒトSerrateタンパク質。
- 脊椎動物のSerrateタンパク質ではない第2のタンパク質のアミノ酸配列に共有結合を介して融合された、請求項1〜5のいずれか1項に記載のタンパク質を含む精製されたキメラタンパク質。
- 請求項1〜5のいずれか1項に記載の脊椎動物のSerrateタンパク質又は請求項6に記載のキメラタンパク質をコードする、単離された核酸。
- 配列番号1、配列番号5、配列番号13および配列番号15からなる群より選択されるヌクレオチド配列を含む、単離された核酸。
- 配列番号3を含む、単離された核酸。
- 請求項7〜9のいずれか1項に記載の核酸を含む核酸ベクター。
- 請求項10に記載の核酸ベクターにより形質転換された組換え細胞。
- 請求項1〜5のいずれか1項に記載の脊椎動物のSerrateタンパク質又は請求項6に記載のキメラタンパク質の生産方法であって、前記タンパク質又はキメラタンパク質が請求項11に記載の組換え細胞によって発現されるように、前記細胞を増殖させること、及び発現した前記タンパク質又はキメラタンパク質を回収することを含む、方法。
- 請求項1〜4のいずれか1項に記載の脊椎動物のSerrateタンパク質と結合する、精製された抗体。
- 請求項5に記載のヒトSerrateタンパク質と結合する、精製された抗体。
- モノクローナル抗体である、請求項13または14に記載の抗体。
- ポリクローナル抗体である、請求項13または14に記載の抗体。
- 請求項1〜5のいずれか1項に記載のタンパク質を用いて宿主動物を免疫すること、及び前記タンパク質と結合する抗体を選択することを含む、請求項13または14に記載の抗体の生産方法。
- ショウジョウバエ(Drosophila)のSerrateタンパク質とは結合しない、請求項13〜16のいずれか1項に記載の抗体。
- 請求項1〜5のいずれか1項に記載の脊椎動物のSerrateタンパク質の誘導体であって、前記脊椎動物のSerrateタンパク質のアミノ酸配列内において、1以上のアミノ酸残基がサイレントな変化を生じる機能的等価物として作用する類似の極性を有する別のアミノ酸によって置換されているアミノ酸配列を有し、且つ脊椎動物のSerrateタンパク質に対する抗体と特異的に結合する、誘導体。
- 請求項4に記載のヒトのSerrateタンパク質と結合する、請求項13に記載の抗体。
- ショウジョウバエ(Drosophila)のSerrateタンパク質とは結合しない、請求項20に記載の抗体。
- 請求項1に記載の脊椎動物のSerrateタンパク質または請求項5に記載のヒトSerrateタンパク質をコードするRNA転写産物の少なくとも15ヌクレオチド部分に絶対的に相補的な配列を含み、且つ前記RNA転写産物にハイブリダイズする、少なくとも15ヌクレオチドを含む単離されたオリゴヌクレオチド。
- 細胞において、請求項1〜5のいずれか1項に記載の脊椎動物のSerrateタンパク質をコードする核酸の発現を抑制する方法であって、前記核酸の発現を抑制するのに有効な量の請求項22に記載のオリゴヌクレオチドをin vitroで前記細胞に供給することを含む、方法。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/400,159 US5869282A (en) | 1991-12-11 | 1995-03-07 | Nucleotide and protein sequences of the serrate gene and methods based thereon |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007260391A Division JP2008099687A (ja) | 1995-03-07 | 2007-10-03 | 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013023179A Division JP2013150605A (ja) | 1995-03-07 | 2013-02-08 | 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010273685A JP2010273685A (ja) | 2010-12-09 |
JP2010273685A5 true JP2010273685A5 (ja) | 2011-07-14 |
Family
ID=23582455
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8527061A Withdrawn JPH11507203A (ja) | 1995-03-07 | 1996-03-07 | 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法 |
JP2007260391A Withdrawn JP2008099687A (ja) | 1995-03-07 | 2007-10-03 | 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法 |
JP2010166570A Withdrawn JP2010273685A (ja) | 1995-03-07 | 2010-07-23 | 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法 |
JP2013023179A Withdrawn JP2013150605A (ja) | 1995-03-07 | 2013-02-08 | 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8527061A Withdrawn JPH11507203A (ja) | 1995-03-07 | 1996-03-07 | 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法 |
JP2007260391A Withdrawn JP2008099687A (ja) | 1995-03-07 | 2007-10-03 | 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013023179A Withdrawn JP2013150605A (ja) | 1995-03-07 | 2013-02-08 | 脊椎動物Serrate遺伝子のヌクレオチドおよびタンパク質配列およびそれらに基づく方法 |
Country Status (11)
Country | Link |
---|---|
US (1) | US5869282A (ja) |
EP (1) | EP0813545B1 (ja) |
JP (4) | JPH11507203A (ja) |
AT (1) | ATE442381T1 (ja) |
AU (1) | AU718955B2 (ja) |
CA (1) | CA2214830C (ja) |
DE (1) | DE69638022D1 (ja) |
DK (1) | DK0813545T3 (ja) |
ES (1) | ES2333384T3 (ja) |
PT (1) | PT813545E (ja) |
WO (1) | WO1996027610A1 (ja) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5869282A (en) * | 1991-12-11 | 1999-02-09 | Imperial Cancer Research Technology, Ltd. | Nucleotide and protein sequences of the serrate gene and methods based thereon |
US6004924A (en) | 1991-12-11 | 1999-12-21 | Imperial Cancer Research Technology, Ltd. | Protein sequences of serrate gene products |
US20050112121A1 (en) * | 1992-04-30 | 2005-05-26 | Yale University | Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
ATE442373T1 (de) * | 1995-06-28 | 2009-09-15 | Imp Cancer Res Tech | Nukleotid- und proteinsequenzen von delta-genen von vertebraten und darauf basierende methoden |
US5780300A (en) * | 1995-09-29 | 1998-07-14 | Yale University | Manipulation of non-terminally differentiated cells using the notch pathway |
US20050158859A1 (en) * | 1995-09-29 | 2005-07-21 | Yale University | Manipulation of non-terminally differentiated cells using the Notch pathway |
WO1997019172A1 (fr) * | 1995-11-17 | 1997-05-29 | Asahi Kasei Kogyo Kabushiki Kaisha | Polypeptide suppresseur et de differenciation |
WO1998002458A1 (fr) | 1996-07-16 | 1998-01-22 | Asahi Kasei Kogyo Kabushiki Kaisha | Inhibiteur de differenciation |
AU773479B2 (en) * | 1996-11-07 | 2004-05-27 | Lorantis Limited | Notch |
US6887475B1 (en) | 1996-11-07 | 2005-05-03 | Lorantis Limited | Notch |
RO120850B1 (ro) * | 1996-11-07 | 2006-08-30 | Imperial College Of Science Technology & Medic | "notch" |
ES2284205T3 (es) | 1997-05-14 | 2007-11-01 | Asahi Kasei Kabushiki Kaisha | Nuevo inhibidor de diferenciacion. |
US6136952A (en) * | 1997-06-25 | 2000-10-24 | University Of Washington | Human jagged polypeptide, encoding nucleic acids and methods of use |
US6436650B1 (en) | 1997-07-23 | 2002-08-20 | Yale University | Activated forms of notch and methods based thereon |
US6692919B1 (en) * | 1997-07-23 | 2004-02-17 | Yale University | Activated forms of notch and methods based thereon |
WO2000025809A1 (en) * | 1998-10-30 | 2000-05-11 | Smith & Nephew Plc | Compositions comprising notch receptor manipulating agents |
US8084258B2 (en) * | 1999-07-12 | 2011-12-27 | University Of Basel | Manipulation of tissue of organ type using the notch pathway |
GB9927328D0 (en) | 1999-11-18 | 2000-01-12 | Lorantis Ltd | Immunotherapy |
US8044259B2 (en) * | 2000-08-03 | 2011-10-25 | The Regents Of The University Of Michigan | Determining the capability of a test compound to affect solid tumor stem cells |
US6984522B2 (en) * | 2000-08-03 | 2006-01-10 | Regents Of The University Of Michigan | Isolation and use of solid tumor stem cells |
US20020151487A1 (en) * | 2000-08-31 | 2002-10-17 | Loyola University Chicago | Method and reagents for epithelial barrier formation and treatment of malignant and benign skin disorders by modulating the notch pathway |
ES2307568T3 (es) * | 2000-12-08 | 2008-12-01 | Coley Pharmaceutical Gmbh | Acidos nucleicos de tipo cpg y metodos de uso de los mismos. |
GB0118155D0 (en) | 2001-07-25 | 2001-09-19 | Lorantis Ltd | Superantigen |
EP1410018A1 (en) * | 2001-07-25 | 2004-04-21 | Lorantis Limited | Method for detecting modultators of notch signalling |
CA2469204A1 (en) * | 2001-12-07 | 2003-06-19 | Regents Of The University Of Michigan | Prospective identification and characterization of breast cancer stem cells |
US20030185829A1 (en) * | 2002-03-12 | 2003-10-02 | Erich Koller | Jagged 2 inhibitors for inducing apoptosis |
US20040102401A1 (en) * | 2002-11-22 | 2004-05-27 | Isis Pharmaceuticals Inc. | Modulation of jagged 1 expression |
GB0300428D0 (en) * | 2003-01-09 | 2003-02-05 | Lorantis Ltd | Medical treatment |
GB0307472D0 (en) * | 2003-04-01 | 2003-05-07 | Lorantis Ltd | Medical treatment |
EP1639090A4 (en) * | 2003-06-09 | 2008-04-16 | Univ Michigan | COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER |
AU2005209909B8 (en) * | 2004-02-03 | 2009-01-15 | The Regents Of The University Of Michigan | Compositions and methods for characterizing, regulating, diagnosing, and treating cancer |
US20060252073A1 (en) * | 2005-04-18 | 2006-11-09 | Regents Of The University Of Michigan | Compositions and methods for the treatment of cancer |
US20070099209A1 (en) * | 2005-06-13 | 2007-05-03 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
WO2006138275A2 (en) * | 2005-06-13 | 2006-12-28 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
US7723477B2 (en) | 2005-10-31 | 2010-05-25 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth |
AU2006308847C1 (en) * | 2005-10-31 | 2012-05-10 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for treating and diagnosing cancer |
EP1961065A4 (en) | 2005-10-31 | 2009-11-11 | Oncomed Pharm Inc | COMPOSITIONS AND METHOD FOR DIAGNOSIS AND TREATMENT OF CANCER |
WO2008121102A2 (en) * | 2006-02-21 | 2008-10-09 | The Regents Of The University Of Michigan | Hedgehog signaling pathway antagonist cancer treatment |
US8148147B2 (en) * | 2007-01-24 | 2012-04-03 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing pancreatic cancer |
WO2008140826A1 (en) * | 2007-05-15 | 2008-11-20 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for diagnosing and treating cancer |
BRPI0919473A2 (pt) | 2008-09-26 | 2017-08-29 | Oncomed Pharm Inc | Agentes de ligação frizzled e usos dos mesmos |
WO2011063237A2 (en) | 2009-11-19 | 2011-05-26 | Oncomed Pharmaceuticals, Inc. | Jagged-binding agents and uses thereof |
TWI535445B (zh) | 2010-01-12 | 2016-06-01 | 安可美德藥物股份有限公司 | Wnt拮抗劑及治療和篩選方法 |
NZ602700A (en) | 2010-04-01 | 2014-10-31 | Oncomed Pharm Inc | Frizzled-binding agents and uses thereof |
US20130095079A1 (en) | 2010-04-09 | 2013-04-18 | Fred Hutchinson Cancer Research Center | Compositions and methods for providing hematopoietic function without hla matching |
CA3090548A1 (en) | 2010-04-09 | 2011-10-13 | Fred Hutchinson Cancer Research Center | Compositions and methods for providing hematopoietic function |
CA2858069C (en) | 2011-12-08 | 2020-02-11 | Fred Hutchinson Cancer Research Center | Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells |
BR112014031689A2 (pt) | 2012-06-22 | 2017-07-25 | Cytomx Therapeutics Inc | anticorpos reativos cruzados anti-jagged 1/jagged 2, anticorpos anti-jagged ativáveis e métodos de uso deles |
CA2887711A1 (en) | 2012-10-23 | 2014-05-01 | Oncomed Pharmaceuticals, Inc. | Methods of treating neuroendocrine tumors using wnt pathway-binding agents |
AU2014205662B2 (en) | 2013-01-08 | 2019-09-05 | Fred Hutchinson Cancer Research Center | Compositions and methods for expansion of embryonic hematopoietic stem cells |
AU2014212081A1 (en) | 2013-02-04 | 2015-08-13 | Oncomed Pharmaceuticals, Inc. | Methods and monitoring of treatment with a Wnt pathway inhibitor |
US9168300B2 (en) | 2013-03-14 | 2015-10-27 | Oncomed Pharmaceuticals, Inc. | MET-binding agents and uses thereof |
US20160250258A1 (en) | 2013-10-31 | 2016-09-01 | Fred Hutchinson Cancer Research Center | Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof |
EP3247808B1 (en) | 2015-01-21 | 2021-05-05 | Fred Hutchinson Cancer Research Center | Point-of-care and/or portable platform for gene therapy |
US11827904B2 (en) | 2015-04-29 | 2023-11-28 | Fred Hutchinson Cancer Center | Modified stem cells and uses thereof |
US20180355318A1 (en) | 2015-04-29 | 2018-12-13 | Fred Hutchinson Cancer Research Center | Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof |
WO2017096347A1 (en) | 2015-12-04 | 2017-06-08 | Fred Hutchinson Cancer Research Center | Uses of expanded populations of hematopoietic stem/progenitor cells |
US11617745B2 (en) | 2018-08-17 | 2023-04-04 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by downregulating FOXO |
WO2020037323A1 (en) * | 2018-08-17 | 2020-02-20 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by upregulating jag-1 |
CN112680471B (zh) * | 2019-10-17 | 2023-08-01 | 华南农业大学 | ZmSPL基因在调控玉米柱头乳突细胞发育中的应用 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4889818A (en) | 1986-08-22 | 1989-12-26 | Cetus Corporation | Purified thermostable enzyme |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5116742A (en) | 1986-12-03 | 1992-05-26 | University Patents, Inc. | RNA ribozyme restriction endoribonucleases and methods |
US4795699A (en) | 1987-01-14 | 1989-01-03 | President And Fellows Of Harvard College | T7 DNA polymerase |
US4981784A (en) * | 1987-12-02 | 1991-01-01 | The Salk Institute For Biological Studies | Retinoic acid receptor method |
IL101728A (en) * | 1991-05-03 | 2007-08-19 | Univ Yale | Human Abandonment and Delta, Restrictive Areas of Effect in Tophoric Proteins, and Methods Based on Them |
US5869282A (en) * | 1991-12-11 | 1999-02-09 | Imperial Cancer Research Technology, Ltd. | Nucleotide and protein sequences of the serrate gene and methods based thereon |
WO1993012141A1 (en) * | 1991-12-11 | 1993-06-24 | Yale University | Nucleotide and protein sequences of the serrate gene and methods based thereon |
US5786158A (en) * | 1992-04-30 | 1998-07-28 | Yale University | Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
WO1997019172A1 (fr) * | 1995-11-17 | 1997-05-29 | Asahi Kasei Kogyo Kabushiki Kaisha | Polypeptide suppresseur et de differenciation |
JP2000512134A (ja) * | 1996-05-31 | 2000-09-19 | ザ ナショナル アメリカン レッド クロス | Jagged/Notchタンパク質および核酸に基づく治療および診断の方法および組成物 |
AU8003400A (en) * | 1999-10-06 | 2001-05-10 | Ansgar H. Santel | Mitofusins, fzo homologs and functional derivatives thereof |
JP5890756B2 (ja) | 2012-06-28 | 2016-03-22 | 昭和電工株式会社 | 磁気記録媒体及び磁気記憶装置 |
-
1995
- 1995-03-07 US US08/400,159 patent/US5869282A/en not_active Expired - Lifetime
-
1996
- 1996-03-07 JP JP8527061A patent/JPH11507203A/ja not_active Withdrawn
- 1996-03-07 AT AT96911262T patent/ATE442381T1/de active
- 1996-03-07 ES ES96911262T patent/ES2333384T3/es not_active Expired - Lifetime
- 1996-03-07 PT PT96911262T patent/PT813545E/pt unknown
- 1996-03-07 AU AU54202/96A patent/AU718955B2/en not_active Expired
- 1996-03-07 DK DK96911262T patent/DK0813545T3/da active
- 1996-03-07 WO PCT/US1996/003172 patent/WO1996027610A1/en active Application Filing
- 1996-03-07 EP EP96911262A patent/EP0813545B1/en not_active Expired - Lifetime
- 1996-03-07 CA CA2214830A patent/CA2214830C/en not_active Expired - Lifetime
- 1996-03-07 DE DE69638022T patent/DE69638022D1/de not_active Expired - Lifetime
-
2007
- 2007-10-03 JP JP2007260391A patent/JP2008099687A/ja not_active Withdrawn
-
2010
- 2010-07-23 JP JP2010166570A patent/JP2010273685A/ja not_active Withdrawn
-
2013
- 2013-02-08 JP JP2013023179A patent/JP2013150605A/ja not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010273685A5 (ja) | ||
JP2017513479A5 (ja) | ||
JP2005120106A5 (ja) | ||
JP2012095652A5 (ja) | ||
JP2012522501A5 (ja) | ||
JP2008538183A5 (ja) | ||
JP2016502512A5 (ja) | ||
JP2009148257A5 (ja) | ||
JP2013509879A5 (ja) | ||
JP2014506790A5 (ja) | ||
JP2013502226A5 (ja) | ||
JP2012000112A5 (ja) | ||
JP2007530435A5 (ja) | ||
JP2007175057A5 (ja) | ||
JP2013530689A5 (ja) | ||
NZ600348A (en) | Anti-c5a binding moieties with high blocking activity | |
JP2014514921A5 (ja) | ||
JP2013063981A5 (ja) | ||
JP2012503478A5 (ja) | ||
JP2013523179A5 (ja) | ||
JP2010539926A5 (ja) | ||
UA110599C2 (uk) | Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку | |
JP2012519489A5 (ja) | ||
JP2009527226A5 (ja) | ||
JP2009136300A5 (ja) |